---

Innovation of a Novel Therapeutic Modality for Treatment of Osteoarthritis of Knee with Autologous Adipose Derived Stromal Vascular Fraction (AD-SVF)

Full Text PDF

---

Original Article

Author Details : Prashant Kshatriya, Anant Marathe, Jaymesh Thadani, Shivani Vakodikar, Rajni Vyas, Ramesh Bhonde

Volume : 3, Issue : 2, Year : 2017

Article Page : 59-66

Suggest article by email

Get Permission

Abstract

Background: Adipose tissue derived stromal vascular fraction is crude heterogeneous mixture of different cell population. SVF possess potential to translate into oesteogenic and chondrogenic lineage. We designed a pilot study to assess safety and efficacy of autologous adipose derived stromal vascular fraction (AD-SVF) in 25 patients (50 knees) with both the knees having osteoarthritis.
Methods: Patients were selected based on selection criteria. Lipoaspiration from the lower abdomen was done. The lipoaspirate was processed to obtain SVF. The intra-articular injection of SVF and PRP was given. Clinical outcomes were assessed with WOMAC, KSS, and VAS scores and radiologically at the interval of 6 weeks, 6 months and 1 year.
Results: The safety of AD-SVF was confirmed as there were no adverse reactions related to therapy. Patients exhibited rapid and progressive improvement of WOMAC, KSS and VAS Score by 1 year. MRI studies did not show radiological evidence of cartilage.
Conclusions: AD-SVF therapy is safe & efficacious alternative treatment for knee osteoarthritis. The intervention is simple, minimally invasive, require minimal hospitalization and surgery.

Keywords: Osteoarthritis, Adipose derived Stromal Vascular Fraction, Stem cell, alternate therapeutic intervention

How to cite : Kshatriya P, Marathe A, Thadani J, Vakodikar S, Vyas R, Bhonde R, Innovation of a Novel Therapeutic Modality for Treatment of Osteoarthritis of Knee with Autologous Adipose Derived Stromal Vascular Fraction (AD-SVF). IP Int J Orthop Rheumatol 2017;3(2):59-66

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.